BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11556915)

  • 1. Interactions between components of the essential oil of Melaleuca alternifolia.
    Cox SD; Mann CM; Markham JL
    J Appl Microbiol; 2001 Sep; 91(3):492-7. PubMed ID: 11556915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia.
    Carson CF; Riley TV
    J Appl Bacteriol; 1995 Mar; 78(3):264-9. PubMed ID: 7730203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Melaleuca alternifolia (tea tree) essential oil and the major monoterpene component terpinen-4-ol on the development of single- and multistep antibiotic resistance and antimicrobial susceptibility.
    Hammer KA; Carson CF; Riley TV
    Antimicrob Agents Chemother; 2012 Feb; 56(2):909-15. PubMed ID: 22083482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial effects of tea-tree oil and its major components on Staphylococcus aureus, Staph. epidermidis and Propionibacterium acnes.
    Raman A; Weir U; Bloomfield SF
    Lett Appl Microbiol; 1995 Oct; 21(4):242-5. PubMed ID: 7576514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broth micro-dilution method for determining the susceptibility of Escherichia coli and Staphylococcus aureus to the essential oil of Melaleuca alternifolia (tea tree oil).
    Carson CF; Hammer KA; Riley TV
    Microbios; 1995; 82(332):181-5. PubMed ID: 7630326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of organic matter, cations and surfactants on the antimicrobial activity of Melaleuca alternifolia (tea tree) oil in vitro.
    Hammer KA; Carson CF; Riley TV
    J Appl Microbiol; 1999 Mar; 86(3):446-52. PubMed ID: 10196749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dynamics and mechanism of the antimicrobial activity of tea tree oil against bacteria and fungi.
    Li WR; Li HL; Shi QS; Sun TL; Xie XB; Song B; Huang XM
    Appl Microbiol Biotechnol; 2016 Oct; 100(20):8865-75. PubMed ID: 27388769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes.
    Hart PH; Brand C; Carson CF; Riley TV; Prager RH; Finlay-Jones JJ
    Inflamm Res; 2000 Nov; 49(11):619-26. PubMed ID: 11131302
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Noumi E; Merghni A; M Alreshidi M; Haddad O; Akmadar G; De Martino L; Mastouri M; Ceylan O; Snoussi M; Al-Sieni A; De Feo V
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30336602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of habituation to tea tree (Melaleuca alternifolia) oil on the subsequent susceptibility of Staphylococcus spp. to antimicrobials, triclosan, tea tree oil, terpinen-4-ol and carvacrol.
    Thomsen NA; Hammer KA; Riley TV; Van Belkum A; Carson CF
    Int J Antimicrob Agents; 2013 Apr; 41(4):343-51. PubMed ID: 23481659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance of Pseudomonas aeruginosa to Melaleuca alternifolia (tea tree) oil is associated with the outer membrane and energy-dependent cellular processes.
    Longbottom CJ; Carson CF; Hammer KA; Mee BJ; Riley TV
    J Antimicrob Chemother; 2004 Aug; 54(2):386-92. PubMed ID: 15254026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species.
    Mondello F; De Bernardis F; Girolamo A; Cassone A; Salvatore G
    BMC Infect Dis; 2006 Nov; 6():158. PubMed ID: 17083732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of pseudomonads to Melaleuca alternifolia (tea tree) oil and components.
    Papadopoulos CJ; Carson CF; Hammer KA; Riley TV
    J Antimicrob Chemother; 2006 Aug; 58(2):449-51. PubMed ID: 16735435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outer membrane of Pseudomonas aeruginosa NCTC 6749 contributes to its tolerance to the essential oil of Melaleuca alternifolia (tea tree oil).
    Mann CM; Cox SD; Markham JL
    Lett Appl Microbiol; 2000 Apr; 30(4):294-7. PubMed ID: 10792649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil.
    Hammer KA; Carson CF; Riley TV
    Antimicrob Agents Chemother; 1999 Jan; 43(1):196. PubMed ID: 10094671
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy.
    Carson CF; Mee BJ; Riley TV
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1914-20. PubMed ID: 12019108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plants of the Melaleuca Genus as Antimicrobial Agents: From Farm to Pharmacy.
    Sharifi-Rad J; Salehi B; Varoni EM; Sharopov F; Yousaf Z; Ayatollahi SA; Kobarfard F; Sharifi-Rad M; Afdjei MH; Sharifi-Rad M; Iriti M
    Phytother Res; 2017 Oct; 31(10):1475-1494. PubMed ID: 28782167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro.
    Brand C; Ferrante A; Prager RH; Riley TV; Carson CF; Finlay-Jones JJ; Hart PH
    Inflamm Res; 2001 Apr; 50(4):213-9. PubMed ID: 11392609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melaleuca alternifolia (tea tree) oil and its monoterpene constituents in treating protozoan and helminthic infections.
    Lam NS; Long X; Su XZ; Lu F
    Biomed Pharmacother; 2020 Oct; 130():110624. PubMed ID: 33503761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp.
    Hammer KA; Carson CF; Riley TV
    J Antimicrob Chemother; 1998 Nov; 42(5):591-5. PubMed ID: 9848442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.